Valuation: Enovis Corporation

Market Cap 1.7B 1.49B 1.39B 1.28B 2.39B 162B 2.44B 16.47B 6.45B 80.51B 6.38B 6.24B 278B P/E 2026 *
246x
P/E 2027 * 30.6x
Enterprise Value 2.91B 2.55B 2.38B 2.18B 4.09B 278B 4.17B 28.18B 11.03B 138B 10.91B 10.67B 476B EV / Sales 2026 *
1.24x
EV / Sales 2027 * 1.12x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+0.56%
1 week+12.05%
Current month+43.72%
1 month+35.10%
3 months+32.28%
6 months+31.00%
Current year+11.67%
1 week 25.4
Extreme 25.4
30.23
1 month 19.14
Extreme 19.14
30.23
Current year 19.14
Extreme 19.14
30.23
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
65.03
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/6/26 Free

Director

846 0.0015%
15/6/26 Buy

Chief Administrative Officer

1,000 0.0017%
11/6/26 Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%+12.05%+8.89%-53.44% 1.7B
+0.99%+13.61%-12.29%+23.97% 133B
+0.73%+8.49%+2.88%+2.45% 13.43B
+3.34%+1.27%+65.10%+100.67% 8.88B
+1.19%+5.60%-44.17%-69.43% 4.71B
-2.12%-1.89%-1.61%+35.57% 2.63B
+0.38%-1.97%-18.67%-25.95% 1.62B
-1.19%+0.88%-26.36%-34.82% 1.61B
+0.32%+2.81%-60.02%-82.00% 1.5B
Average +0.51%+1.56%-9.58%-11.44% 18.77B
Weighted average by Cap. +1.03%+4.78%-8.14%+21.11%

Financials

2026 *2027 *
Net sales 2.34B 2.06B 1.92B 1.76B 3.3B 224B 3.36B 22.73B 8.9B 111B 8.8B 8.61B 384B 2.47B 2.16B 2.02B 1.85B 3.47B 236B 3.53B 23.91B 9.36B 117B 9.26B 9.06B 404B
Net income 2.98M 2.62M 2.44M 2.24M 4.2M 285M 4.27M 28.89M 11.31M 141M 11.19M 10.95M 488M 54.14M 47.51M 44.24M 40.69M 76.29M 5.17B 77.59M 525M 205M 2.57B 203M 199M 8.86B
Net Debt 1.21B 1.06B 986M 907M 1.7B 115B 1.73B 11.7B 4.58B 57.18B 4.53B 4.43B 198B 1.07B 938M 873M 803M 1.51B 102B 1.53B 10.36B 4.05B 50.61B 4.01B 3.92B 175B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
29/07/26 US$29.77 +0.83% 125,147
28/07/26 US$29.52 +4.50% 1,301,951
27/07/26 US$28.25 +4.51% 827,686
24/07/26 US$27.03 +3.72% 850,976
23/07/26 US$26.06 -1.85% 826,564
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
29.52USD
Average target price
41.58USD
Spread / Average Target
+40.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock